These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21292299)

  • 21. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
    Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
    Lu Y; Wu LQ; Li CS; Wang SG; Han B
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of gene products of insulin-like-growth-factor II, insulin-like-growth-factor II receptor and colony-stimulating-factor-I receptor in human primary hepatocellular carcinoma and non-cancerous liver tissues].
    Yang D
    Zhonghua Yi Xue Za Zhi; 1992 Aug; 72(8):476-80, 510. PubMed ID: 1337723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the c-met protooncogene in human hepatocellular carcinoma.
    Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
    Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
    Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
    Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
    Wang HT; Wang J; Ou QJ; Liu XP; Chen S
    Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
    Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
    Breuhahn K; Longerich T; Schirmacher P
    Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.
    Suzuki K; Hayashi N; Miyamoto Y; Yamamoto M; Ohkawa K; Ito Y; Sasaki Y; Yamaguchi Y; Nakase H; Noda K; Enomoto N; Arai K; Yamada Y; Yoshihara H; Tujimura T; Kawano K; Yoshikawa K; Kamada T
    Cancer Res; 1996 Jul; 56(13):3004-9. PubMed ID: 8674055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
    Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
    Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
    Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
    Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
    Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.